BioLife Solutions
BLFS
169 hedge funds and large institutions have $1.31B invested in BioLife Solutions in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 52 reducing their positions, and 22 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 52
23% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 22
7.1% more ownership
Funds ownership: 76.96% → 84.06% (+7.1%)
2% more funds holding
Funds holding: 165 → 169 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $1.34B → $1.31B (-$35.5M)
51% less call options, than puts
Call options by funds: $2.35M | Put options by funds: $4.84M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$72.7M |
| 2 |
Jennison Associates
New York
|
+$23.3M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$16.2M |
| 4 |
Millennium Management
New York
|
+$15.9M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$14.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$24.6M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$20.2M |
| 3 |
RA
Royce & Associates
New York
|
-$5.57M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4.88M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$4.44M |
BLFS Hedge Fund Activity: Q4 2021 in Review
169 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2021, worth a combined $1.31B — down 2.6% from $1.34B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new BLFS positions and 22 closed out — a net gain of 5 holders — while 69 added to existing stakes and 52 trimmed.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $72.7M. The largest seller was BlackRock, cutting an estimated $24.6M.
- 169 institutional investors held BioLife Solutions (BLFS) as of Q4 2021, up from 165 in Q3 2021.
- Funds reported $1.31B of BioLife Solutions stock for Q4 2021, down 2.6% quarter-over-quarter.
- 27 funds opened new BioLife Solutions positions in Q4 2021 and 22 closed out, a net change of +5 holders.
- The largest BioLife Solutions buyer in Q4 2021 was Fred Alger Management, an estimated $72.7M added.
- The largest BioLife Solutions seller in Q4 2021 was BlackRock, an estimated $24.6M sold.
Based on aggregated 13F filings for Q4 2021.